News
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Sr ...
Dr. Roberta Lotti honoured for a pioneering work on PC111, reinforcing Scinai's strategic option agreement to acquire the ...
3d
News-Medical.Net on MSNNext generation CAR-T cells push the boundaries of lymphoma treatmentCAR-T cells, which are genetically programmed to specifically recognize and kill target cells, have altered the therapeutic ...
2d
AZoLifeSciences on MSNCombating Tumor Resistance and Exhaustion in LymphomaThe study reviews CAR-T cell advancements in lymphoma treatment, addressing T cell exhaustion and tumor immune evasion with ...
Using quantitative proteomics, the authors uncover that ZMAT3 knockout leads to upregulation of HKDC1, a gene linked to mitochondrial respiration, and that ZMAT3 suppresses HKDC1 expression by ...
Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors (TRAILR1 and TRAILR2) are promising targets for cancer therapy: both recombinant TRAIL and monoclonal antibodies ...
When it comes to CBD oils, there are many to choose from. We share some great options and tips to help you pick the right one for you.
This study aimed to repurpose the antifungal drug flucytosine (FCN) for anticancer activity together with cocrystals of nutraceutical coformers sinapic acid (SNP) and syringic acid (SYA). The ...
FAS – Direxion Daily Financial Bull 3X ETF – Check FAS price, review total assets, see historical growth, and review the analyst rating from Morningstar.
Nucleotide-binding domain leucine-rich repeat family pyrin domain containing 3 (NLRP3) inflammasome complex regulates the caspase-1 activity and subsequent processing of interleukin-1β (IL-1β).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results